In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli

Multidrug-resistant bacteria are a growing global concern, and with increasingly prevalent resistance to last line antibiotics such as colistin, it is imperative that alternative treatment options are identified. Herein we investigated the mechanism of action of a novel antimicrobial peptide (CDP-B1...

Descripción completa

Detalles Bibliográficos
Autores principales: Witherell, Kaitlin S., Price, Jason, Bandaranayake, Ashok D., Olson, James, Call, Douglas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835343/
https://www.ncbi.nlm.nih.gov/pubmed/33495505
http://dx.doi.org/10.1038/s41598-021-81140-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835343/
https://www.ncbi.nlm.nih.gov/pubmed/33495505
http://dx.doi.org/10.1038/s41598-021-81140-8

Ejemplares similares